Home Fujian Province Releases Top 20 Pharmaceutical Sales Ranking for June 2019

Fujian Province Releases Top 20 Pharmaceutical Sales Ranking for June 2019

Aug 08, 2019 10:12 CST Updated 10:12
Pfizer

Pharmaceutical R&D Developer

Sanofi

Pharmaceutical R&D Developer

AstraZeneca

Biopharmaceutical Manufacturer

Bayer

Pharmaceutical Product R&D Developer

Yichang HEC Changjiang Pharmaceutical

Therapeutic Area Product Development and Manufacturing

Hansoh Pharma

Innovative Therapeutic Drug Developer

NCPC

Pharmaceutical Product R&D Developer

Luye Pharma

Innovative Drug Developer

On August 6, the Fujian Provincial Healthcare Security Administration released the “List of Top 20 Drugs by Sales Volume under Fujian Province’s Joint Price-Capped Sunshine Procurement Program (June 2019).” Half of the listed drugs were injections, with Roche Shanghai’s Trastuzumab for Injection ranking first in sales. Notably, although many of the top-selling drugs in Fujian Province in June were from foreign pharmaceutical companies such as Roche Shanghai, Pfizer, Sanofi, AstraZeneca, and Bayer, there were also numerous domestic enterprises represented. Pharmaceutical companies including HEC CJ PHARM, Shanghai Hutchison Pharmaceuticals, Southwest Pharmaceutical, Jiangsu Hansoh Pharmaceutical, CSPC-NBP Pharmaceutical, NCPC, and Sichuan Luye Pharmaceutical all had products among the top 20 in sales volume. Details are provided in the list below:


QQ图片20190808095923.png


Disclaimer: This article is reposted from Yaozhi.com. The copyright belongs to the original author. The purpose of reposting is to convey more information, which does not represent the views of this platform. If there are any issues regarding the content, copyright, or other matters, please leave a message on our website, and we will delete the content promptly.

药智公众号二维码.jpg